Association of Left Atrial Size With Stroke or Systemic Embolism in Patients With Atrial Fibrillation Having Undergone Bioprosthetic Valve Replacement From the BPV-AF Registry
Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear.Methods and Results:...
Saved in:
Published in: | Circulation Reports Vol. 5; no. 5; pp. 210 - 216 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Japan
The Japanese Circulation Society
10-05-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear.Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1–T3) according to LAVI as follows: T1 (n=177), LAVI=21.5–55.3 mL/m2; T2 (n=178), LAVI=55.6–82.1 mL/m2; T3 (n=178), LAVI=82.5–408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1.Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF. |
---|---|
AbstractList | The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear.
Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1-T3) according to LAVI as follows: T1 (n=177), LAVI=21.5-55.3 mL/m
; T2 (n=178), LAVI=55.6-82.1 mL/m
; T3 (n=178), LAVI=82.5-408.0 mL/m
. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1.
Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF. Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear.Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1–T3) according to LAVI as follows: T1 (n=177), LAVI=21.5–55.3 mL/m2; T2 (n=178), LAVI=55.6–82.1 mL/m2; T3 (n=178), LAVI=82.5–408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1.Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF. Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear. Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1-T3) according to LAVI as follows: T1 (n=177), LAVI=21.5-55.3 mL/m2; T2 (n=178), LAVI=55.6-82.1 mL/m2; T3 (n=178), LAVI=82.5-408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1. Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF.Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear. Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1-T3) according to LAVI as follows: T1 (n=177), LAVI=21.5-55.3 mL/m2; T2 (n=178), LAVI=55.6-82.1 mL/m2; T3 (n=178), LAVI=82.5-408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1. Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF. Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear. Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1–T3) according to LAVI as follows: T1 (n=177), LAVI=21.5–55.3 mL/m 2 ; T2 (n=178), LAVI=55.6–82.1 mL/m 2 ; T3 (n=178), LAVI=82.5–408.0 mL/m 2 . The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1. Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF. |
ArticleNumber | CR-23-0007 |
Author | Nawada, Ryuzo Izumi, Chisato Miyake, Makoto Sakamoto, Tomohiro Tanaka, Hidekazu Kimura, Tetsuya Furukawa, Yutaka Kitai, Takeshi Izumo, Masaki Fujita, Tomoyuki Ando, Kenji Sakata, Yasushi Fukui, Toshihiro for the BPV-AF Registry Group Amano, Masashi Eishi, Kiyoyuki Tsujita, Kenichi Nishimura, Kunihiro Komiya, Tatsuhiko Koyama, Tadaaki Yoshida, Kiyoshi Shibata, Yoshisato Takegami, Misa Kimura, Takeshi Minatoya, Kenji Kawai, Hiroya |
Author_xml | – sequence: 1 fullname: Tanaka, Hidekazu organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine – sequence: 2 fullname: Takegami, Misa organization: Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center – sequence: 3 fullname: Miyake, Makoto organization: Department of Cardiology, Tenri Hospital – sequence: 4 fullname: Amano, Masashi organization: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center – sequence: 5 fullname: Kitai, Takeshi organization: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center – sequence: 6 fullname: Fujita, Tomoyuki organization: Cardiovascular Surgery Department, National Cerebral and Cardiovascular Center – sequence: 7 fullname: Koyama, Tadaaki organization: Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital – sequence: 8 fullname: Ando, Kenji organization: Department of Cardiology, Kokura Memorial Hospital – sequence: 9 fullname: Komiya, Tatsuhiko organization: Department of Cardiovascular Surgery, Kurashiki Central Hospital – sequence: 10 fullname: Izumo, Masaki organization: Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine – sequence: 11 fullname: Kawai, Hiroya organization: Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center – sequence: 12 fullname: Eishi, Kiyoyuki organization: Department of Cardiovascular Surgery, Nagasaki University Hospital – sequence: 13 fullname: Yoshida, Kiyoshi organization: Department of Cardiology, The Sakakibara Heart Institute of Okayama – sequence: 14 fullname: Kimura, Takeshi organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University – sequence: 15 fullname: Nawada, Ryuzo organization: Department of Cardiology, Shizuoka City Shizuoka Hospital – sequence: 16 fullname: Sakamoto, Tomohiro organization: Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center – sequence: 17 fullname: Shibata, Yoshisato organization: Department of Cardiology, Miyazaki Medical Association Hospital Cardiovascular Center – sequence: 18 fullname: Fukui, Toshihiro organization: Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kumamoto University – sequence: 19 fullname: Minatoya, Kenji organization: Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University – sequence: 20 fullname: Tsujita, Kenichi organization: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University – sequence: 21 fullname: Sakata, Yasushi organization: Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine – sequence: 22 fullname: Kimura, Tetsuya organization: Primary Medical Science Department, Daiichi Sankyo Co., Ltd – sequence: 23 fullname: Nishimura, Kunihiro organization: Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center – sequence: 24 fullname: Furukawa, Yutaka organization: Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital – sequence: 25 fullname: Izumi, Chisato organization: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center – sequence: 26 fullname: for the BPV-AF Registry Group |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37180478$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkd9u0zAUxiM0xMbYC3CBfMlNhv8lTq5QVy0MqRJTy8al5TonqUcSZ7ZbqbwUr4hHSjfsC1s63_c79vneJieDHSBJ3hN8SWjGPmnjtIPxcr5MKUsxxuJVckY54ykWJT55cT9NLrx_iApKOM8IfpOcMkEKzEVxlvyeeW-1UcHYAdkGLaAJaBacUR1amV-AfpiwQavg7E9A1qHV3gfojUbX_dp2xvfIDOg22mEIfhIf3JVZO9N1E_lG7czQoruhBtfGj6ArY0dnfdhAiLB71e0ALWHslIY-olDlbI9iFV3d3qezKtZa44Pbv0teN6rzcHE4z5O76vr7_CZdfPvydT5bpJozEdKy4FnTFARjQmsCPAcNmWhyqHPAuATO1kQrzLDgJaYFqZuSKJxhUVCdFzVl58nniTtu1z3UOr7JqU6OzvTK7aVVRv5fGcxGtnYnCSZ5XCISPh4Izj5uwQfZG68hTmQAu_UydmVFkYucRymdpDqOxDtojn0Ilk9py0Pacr6UlMmntKPpw8sXHi3_so2CahI8-KBaOAqUiyPv4MjM_u5n8rNgo5yEgf0Bb-nGRw |
Cites_doi | 10.7861/clinmedicine.10-2-168 10.1016/j.jacc.2005.08.077 10.1007/s11748-019-01068-9 10.5603/KP.2016.0172 10.1016/j.cjca.2017.12.008 10.1007/s12574-021-00561-6 10.1093/ehjci/jev014 10.4065/83.10.1107 10.1007/s10557-020-07038-1 10.1093/ejcts/ezac209 10.1161/01.CIR.98.10.946 10.1016/j.echo.2010.05.010 10.2147/CLEP.S47385 10.1007/s10554-021-02403-z 10.1016/S0002-9149(02)02864-3 10.1067/mhj.2003.91 10.1253/circj.CJ-21-0564 10.1016/j.cjca.2017.06.002 |
ContentType | Journal Article |
Copyright | 2023, THE JAPANESE CIRCULATION SOCIETY Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY. Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY 2023 The Japanese Circulation Society 一般社団法人 日本循環器学会 |
Copyright_xml | – notice: 2023, THE JAPANESE CIRCULATION SOCIETY – notice: Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY. – notice: Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY 2023 The Japanese Circulation Society 一般社団法人 日本循環器学会 |
CorporateAuthor | BPV-AF Registry Group for the BPV-AF Registry Group |
CorporateAuthor_xml | – name: BPV-AF Registry Group – name: for the BPV-AF Registry Group |
DBID | NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1253/circrep.CR-23-0007 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2434-0790 |
EndPage | 216 |
ExternalDocumentID | 10_1253_circrep_CR_23_0007 37180478 article_circrep_5_5_5_CR_23_0007_article_char_en |
Genre | Journal Article |
GroupedDBID | 53G ALMA_UNASSIGNED_HOLDINGS JSF JSH M~E OK1 RJT RPM RZJ NPM PGMZT AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c437t-9845ff810012d1e46ece57f6ed6e009e43b1ca0307490281df91a050782c68d23 |
IEDL.DBID | RPM |
ISSN | 2434-0790 |
IngestDate | Tue Sep 17 21:32:32 EDT 2024 Sat Oct 26 04:06:45 EDT 2024 Fri Aug 23 01:01:23 EDT 2024 Sat Nov 02 12:18:27 EDT 2024 Sun Jul 28 05:37:12 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 5 |
Keywords | Bioprosthetic valve replacement Thromboembolism Left atrial volume index Atrial fibrillation |
Language | English |
License | Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY. This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c437t-9845ff810012d1e46ece57f6ed6e009e43b1ca0307490281df91a050782c68d23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Hidekazu Tanaka, MD, PhD, FJCS |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166667/ |
PMID | 37180478 |
PQID | 2813886764 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10166667 proquest_miscellaneous_2813886764 crossref_primary_10_1253_circrep_CR_23_0007 pubmed_primary_37180478 jstage_primary_article_circrep_5_5_5_CR_23_0007_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2023-May-10 |
PublicationDateYYYYMMDD | 2023-05-10 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-May-10 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Circulation Reports |
PublicationTitleAlternate | Circ Rep |
PublicationYear | 2023 |
Publisher | The Japanese Circulation Society |
Publisher_xml | – name: The Japanese Circulation Society |
References | 17. Andrade JG, Macle L, Nattel S, Verma A, Cairns J. Contemporary atrial fibrillation management: A comparison of the current AHA/ACC/HRS, CCS, and ESC guidelines. Can J Cardiol 2017; 33: 965–976. 13. Furukawa Y, Miyake M, Fujita T, Koyama T, Takegami M, Kimura T, et al. Rationale, design, and baseline characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study. Cardiovasc Drugs Ther 2020; 34: 689–696. 4. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6: 213–220. 10. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, et al. Prediction of cardiovascular outcomes with left atrial size: Is volume superior to area or diameter? J Am Coll Cardiol 2006; 47: 1018–1023. 16. Zhan Y, Joza J, Al Rawahi M, Barbosa RS, Samuel M, Bernier M, et al. Assessment and management of the left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol 2018; 34: 252–261. 8. Fatema K, Bailey KR, Petty GW, Meissner I, Osranek M, Alsaileek AA, et al. Increased left atrial volume index: Potent biomarker for first-ever ischemic stroke. Mayo Clin Proc 2008; 83: 1107–1115. 19. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685–713; quiz 786–788. 3. Ray S. Changing epidemiology and natural history of valvular heart disease. Clin Med (Lond) 2010; 10: 168–171. 11. Shiraki H, Tanaka H, Yamauchi Y, Yoshigai Y, Yamashita K, Tanaka Y, et al. Characteristics of non-valvular atrial fibrillation with left atrial appendage thrombus who are undergoing appropriate oral anticoagulation therapy. Int J Cardiovasc Imaging 2022; 38: 941–951. 1. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery; Shimizu H, Endo S, Natsugoe S, Doki Y, Hirata Y, et al. Thoracic and cardiovascular surgery in Japan in 2016: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2019; 67: 377–411. 2. Hollenberg SM. Valvular heart disease in adults: Etiologies, classification, and diagnosis. FP Essent 2017; 457: 11–16. 14. Izumi C, Miyake M, Fujita T, Koyama T, Tanaka H, Ando K, et al. Antithrombotic therapy for patients with atrial fibrillation and bioprosthetic valves: Real-world data from the multicenter, prospective, observational BPV-AF Registry. Circ J 2022; 86: 440–448. 9. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284–1289. 6. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893–2962. 20. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561–632. 18. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003; 145: 676–682. 12. Suwa Y, Miyasaka Y, Taniguchi N, Harada S, Nakai E, Shiojima I. Atrial fibrillation and stroke: Importance of left atrium as assessed by echocardiography. J Echocardiogr 2022; 20: 69–76. 15. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 233–270. 7. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1–e76. 5. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946–952. 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 10 |
References_xml | – ident: 2 – ident: 3 doi: 10.7861/clinmedicine.10-2-168 – ident: 10 doi: 10.1016/j.jacc.2005.08.077 – ident: 1 doi: 10.1007/s11748-019-01068-9 – ident: 6 doi: 10.5603/KP.2016.0172 – ident: 16 doi: 10.1016/j.cjca.2017.12.008 – ident: 12 doi: 10.1007/s12574-021-00561-6 – ident: 15 doi: 10.1093/ehjci/jev014 – ident: 8 doi: 10.4065/83.10.1107 – ident: 13 doi: 10.1007/s10557-020-07038-1 – ident: 20 doi: 10.1093/ejcts/ezac209 – ident: 5 doi: 10.1161/01.CIR.98.10.946 – ident: 19 doi: 10.1016/j.echo.2010.05.010 – ident: 4 doi: 10.2147/CLEP.S47385 – ident: 11 doi: 10.1007/s10554-021-02403-z – ident: 7 – ident: 9 doi: 10.1016/S0002-9149(02)02864-3 – ident: 18 doi: 10.1067/mhj.2003.91 – ident: 14 doi: 10.1253/circj.CJ-21-0564 – ident: 17 doi: 10.1016/j.cjca.2017.06.002 |
SSID | ssj0002144510 |
Score | 1.8826141 |
Snippet | Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the... The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI... Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the... |
SourceID | pubmedcentral proquest crossref pubmed jstage |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 210 |
SubjectTerms | Atrial fibrillation Bioprosthetic valve replacement Left atrial volume index Original article Thromboembolism Valvular Heart Disease |
Title | Association of Left Atrial Size With Stroke or Systemic Embolism in Patients With Atrial Fibrillation Having Undergone Bioprosthetic Valve Replacement From the BPV-AF Registry |
URI | https://www.jstage.jst.go.jp/article/circrep/5/5/5_CR-23-0007/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/37180478 https://www.proquest.com/docview/2813886764 https://pubmed.ncbi.nlm.nih.gov/PMC10166667 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Circulation Reports, 2023/05/10, Vol.5(5), pp.210-216 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELboigMXBOJVWNAgcUNpN3Gep1W3NOoBULWFhVvkOHabpUmqNOXAn-IvMuMk3RZxIjl6rDiZif2NPfMNY-98R_iRsNFT1e4FOigys6JAaCsUme2kws-0yVubL4PP38MPM6LJ8ftcGBO0L9N8VG6KUZmvTWzltpDjPk5svPg0JY8Tr2A8YAMEh0c-Os2_RAKGltZlyDgeH8u8Rgi2HU2vLYdTHnVwsgrdv0UgtlL_wph_h0oerT3xI_awA40waQf3mN1T5RP2--jLQqXho9INTEwVDljmvxR8y5s1LJu6-qGgqqHlJs8lzIq02uS7AvISFi2t6q4V7nrHlAawaYPkYC5oywFMfaRVVSq4yqstpYqsKf0RbsTmpwKE8bQdTzuNENdVAdgKV4sbaxJj28pUlHvKvsazL9O51ZVfsKTLg8aKQtfTOiSSJiezlesrqbxA-yrzFSIz5fLUloImCZcoYOxMR7a48AhzSD_MHP6MnZU4rhcMNOcR-jHKiZR0dYput9SuRjDKid4u40P2vldHsm1ZNhLyTlB5Sae8ZHqdOJzOyoMhu2w1dpDtjOMg65n7rsedwFrUOB8M2dte1Qn-TnRGIkpV7XcJvgcPQz_w3SF73qr-8BSO6ziRGQ1ZeGIUBwGi6j5tQQs2lN29xb78_66v2AMqdW8Z5thzdtbUe_WaDXbZ_o2x_z9UTBKf |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbYBQkuPMSry2uQuKG0SZznCXVLoyK6q2q7LNwi17HbsG1SpSkH_hR_kZk8ui3itMnRY8XRjO1v7JlvGPvg2cILhYWeqnZMdFBkYoS-0EYgEsueCS_RVd7aaOqf_wg-D4kmx2tzYaqgfTlLu9ly1c3SRRVbuV7JXhsn1pucDcjjxMfvHbG7OGFNc89LpxWYaMDQ1pocGdvlPZkWCMLW3cGFYXPKpPYP9qF7PxGKzdX_UOa_wZJ7u0_06LbjfsweNngT-nX7E3ZHZU_Znz2lQK5hrHQJ_aqAB0zT3wq-p-UCpmWRXyvIC6hpzVMJw9UsX6abFaQZTGpG1k0t3PSOKINgWcfXwUjQaQVUpZXmeabgNM3XlGWyoMxJuBLLXwrQA6CTfDqkhKjIV4CtcDq5MvoRts2rYnTP2LdoeDkYGU3lBkM63C-NMHBcrQPid7ITSzmeksr1tacSTyGoUw6fWVLQ-uIQe4yV6NASpktwRXpBYvPn7DjDcb1koDkP0QVSdqiko2fosUvtaMSxnJjxEt5hH1s9xuuaoCMmxwa1HjdajwcXsc3pmt3vsE-1qneyjX52sm713vS4EViIApeSDnvf2kiMM5GuV0Sm8u0mxv_gQeD5ntNhL2qb2X2FIwQgHqQOCw6saSdALN-HLWhEFdt3azQnt-_6jt0fXZ6N4_GX86-v2APbtKuYTct8zY7LYqvesKNNsn1bTaK_omMoWQ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYBSEuPMSrPAeJG0qb2GkeXFC326iIZVVtYeEWuY7dBtokSlMO_Cn-IjNJ2m0RJ0iOHiuOZmzPZ898w9hrj0svlA4iVePaCFBUYoW-NFYgE4fPpJeYOm9tPPXPvwanI6LJebvNhamD9tUs7WbLVTdLF3VsZbFSvW2cWG_ycUiIEx-_VySmd8Su46S1-R5Sp1WYqMDQ3to8Gd4XPZWW6IgV3eGFxQVlU_sHe9GNb-iOzfXfPM0_Ayb3dqDozv-M_S673fqdMGhk7rFrOrvPfu0pB3IDZ9pUMKgLecA0_anhS1otYFqV-XcNeQkNvXmqYLSa5ct0vYI0g0nDzLpuhNveEWUSLJs4OxhLOrWAusTSPM80nKR5QdkmC8qghEu5_KEBkQCd6NNhJURlvgJshZPJpTWIsG1eF6V7wD5Ho0_DsdVWcLCUK_zKCgO3b0xAPE88cbTraaX7vvF04ml07rQrZo6StM64xCLjJCZ0pN0nt0V5QcLFQ3ac4bgeMzBChAiFNA-1cs0MkbsyrkF_VhBDXiI67M1Wl3HREHXEBHBQ83Gr-Xh4EXNB1-1-h71r1L2TbXW0k-3X71WPK4GFLHFJ6bBXWzuJcUbSNYvMdL5Zx_gfIgg833M77FFjN7uvCHQFiA-pw4IDi9oJENv3YQsaUs36vTWcJ__e9SW7OTmN4rP35x-eslvc5nXopmM_Y8dVudHP2dE62byo59Fvt9Yq2Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+Left+Atrial+Size+With+Stroke+or+Systemic+Embolism+in+Patients+With+Atrial+Fibrillation+Having+Undergone+Bioprosthetic+Valve+Replacement+From+the+BPV-AF+Registry&rft.jtitle=Circulation+reports&rft.au=Tanaka%2C+Hidekazu&rft.au=Takegami%2C+Misa&rft.au=Miyake%2C+Makoto&rft.au=Amano%2C+Masashi&rft.date=2023-05-10&rft.issn=2434-0790&rft.eissn=2434-0790&rft.volume=5&rft.issue=5&rft.spage=210&rft_id=info:doi/10.1253%2Fcircrep.CR-23-0007&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2434-0790&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2434-0790&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2434-0790&client=summon |